Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms

Overview

Journal Pathogens

Date 2022 Feb 26

PMID 35215212

Authors

Qing Han

Bang Zheng

Luke Daines

Aziz Sheikh

Affiliations

Soon will be listed here.

Abstract

Emerging evidence has shown that COVID-19 survivors could suffer from persistent symptoms. However, it remains unclear whether these symptoms persist over the longer term. This study aimed to systematically synthesise evidence on post-COVID symptoms persisting for at least 12 months. We searched PubMed and Embase for papers reporting at least one-year follow-up results of COVID-19 survivors published by 6 November 2021. Random-effects meta-analyses were conducted to estimate pooled prevalence of specific post-COVID symptoms. Eighteen papers that reported one-year follow-up data from 8591 COVID-19 survivors were included. Fatigue/weakness (28%, 95% CI: 18-39), dyspnoea (18%, 95% CI: 13-24), arthromyalgia (26%, 95% CI: 8-44), depression (23%, 95% CI: 12-34), anxiety (22%, 95% CI: 15-29), memory loss (19%, 95% CI: 7-31), concentration difficulties (18%, 95% CI: 2-35), and insomnia (12%, 95% CI: 7-17) were the most prevalent symptoms at one-year follow-up. Existing evidence suggested that female patients and those with more severe initial illness were more likely to suffer from the sequelae after one year. This study demonstrated that a sizeable proportion of COVID-19 survivors still experience residual symptoms involving various body systems one year later. There is an urgent need for elucidating the pathophysiologic mechanisms and developing and testing targeted interventions for long-COVID patients.

Citing Articles

DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 ( and ), TMPRSS2 ( and ) and ACE1 Polymorphisms in COVID-19 Survivors with Post-COVID-19 Condition.

Fernandez-de-Las-Penas C, Diaz-Gil G, Gil-Crujera A, Gomez-Sanchez S, Ambite-Quesada S, Torres-Macho J Int J Mol Sci. 2025; 26(5).

PMID: 40076720 PMC: 11900996. DOI: 10.3390/ijms26052100.

Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities.

Cruz-Santiago D, Meng X, Canac-Marquis M, Sengupta A, Brassard J, Pavey E Can Geriatr J. 2025; 28(1):67-72.

PMID: 40051588 PMC: 11882206. DOI: 10.5770/cgj.28.770.

Assessment of psychosocial aspects in adults in post-COVID-19 condition: the EURONET-SOMA recommendations on core outcome domains for clinical and research use.

Salzmann S, de Vroege L, Engelmann P, Fink P, Fischer S, Frisch S BMC Med. 2025; 23(1):81.

PMID: 39934846 PMC: 11818037. DOI: 10.1186/s12916-025-03927-0.

Healthcare utilization patterns before and after a long COVID diagnosis: a case-control study.

DeVoss R, Carlton E, Jolley S, Perraillon M BMC Public Health. 2025; 25(1):514.

PMID: 39930426 PMC: 11812174. DOI: 10.1186/s12889-025-21393-4.

Prevalence of and risk factors for long COVID following infection with the COVID‑19 omicron variant.

Moritani I, Yamanaka K, Nakamura T, Tanaka J, Kainuma K, Okamoto M Med Int (Lond). 2025; 5(2):17.

PMID: 39927297 PMC: 11803340. DOI: 10.3892/mi.2025.216.

References

Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B . Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw Open. 2021; 4(9):e2127403. PMC: 8482055. DOI: 10.1001/jamanetworkopen.2021.27403. View

Rank A, Tzortzini A, Kling E, Schmid C, Claus R, Loll E . One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms. J Clin Med. 2021; 10(15). PMC: 8347559. DOI: 10.3390/jcm10153305. View

Perez Catalan I, Roig Marti C, Palomo de la Sota D, Cardenal Alvarez A, Esteve Gimeno M, Fabra Juana S . Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. J Med Virol. 2021; 94(1):205-210. PMC: 8662039. DOI: 10.1002/jmv.27296. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Topp C, Ostergaard S, Sondergaard S, Bech P . The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015; 84(3):167-76. DOI: 10.1159/000376585. View

Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Florencio L, Cuadrado M, Plaza-Manzano G . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021; 92:55-70. PMC: 8206636. DOI: 10.1016/j.ejim.2021.06.009. View

Blevins C, Weathers F, Davis M, Witte T, Domino J . The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015; 28(6):489-98. DOI: 10.1002/jts.22059. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Yusuf F, Fahriani M, Mamada S, Frediansyah A, Abubakar A, Maghfirah D . Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res. 2021; 10:301. PMC: 8171196. DOI: 10.12688/f1000research.52216.1. View

10.

Fernandez-de-Las-Penas C, Guijarro C, Plaza-Canteli S, Hernandez-Barrera V, Torres-Macho J . Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung. 2021; 199(3):249-253. PMC: 8124095. DOI: 10.1007/s00408-021-00450-w. View

11.

Mendez R, Balanza-Martinez V, Luperdi S, Estrada I, Latorre A, Gonzalez-Jimenez P . Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study. J Intern Med. 2021; 291(2):247-251. PMC: 8662064. DOI: 10.1111/joim.13389. View

12.

Mahler D, Wells C . Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93(3):580-6. DOI: 10.1378/chest.93.3.580. View

13.

Krupp L, Larocca N, Steinberg A . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989; 46(10):1121-3. DOI: 10.1001/archneur.1989.00520460115022. View

14.

Wynberg E, van Willigen H, Dijkstra M, Boyd A, Kootstra N, van den Aardweg J . Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset. Clin Infect Dis. 2021; 75(1):e482-e490. PMC: 8522402. DOI: 10.1093/cid/ciab759. View

15.

Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo A, Capriotti V, DAlessandro A . Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021; 11(12):1685-1688. PMC: 9291310. DOI: 10.1002/alr.22832. View

16.

Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K . Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clin Infect Dis. 2021; 74(11):1953-1965. PMC: 9187317. DOI: 10.1093/cid/ciab703. View

17.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

18.

Boscolo-Rizzo P, Hummel T, Hopkins C, Dibattista M, Menini A, Spinato G . High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021; 59(6):517-527. DOI: 10.4193/Rhin21.249. View

19.

Gamberini L, Mazzoli C, Prediletto I, Sintonen H, Scaramuzzo G, Allegri D . Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respir Med. 2021; 189:106665. PMC: 8531241. DOI: 10.1016/j.rmed.2021.106665. View

20.

Nyaga V, Arbyn M, Aerts M . Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2015; 72(1):39. PMC: 4373114. DOI: 10.1186/2049-3258-72-39. View